PCOS as a Metabolic Condition: GLP-1s and Rising Prevalence

GLP-1 drugs show promise for PCOS, reducing weight and androgens. A large Chinese study reports rising PCOS prevalence in pregnancy (0.79 to 19.0 per 10k) with increased maternal-fetal risks. The condition is being reframed as Polyendocrine Metabolic Ovarian Syndrome.